Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal – A cross-sectional and retrospective observational study

IntroductionExtensively drug-resistant Pseudomonas aeruginosa (XDR-PA) is a growing concern due to its increasing incidence, limited therapeutic options, limited data on the optimal treatment, and high mortality rates. The study aimed to characterize the population, the outcome and the microbiologic...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Diogo Mendes Pedro, Sérgio Eduardo Paulo, Carla Mimoso Santos, Ana Bruschy Fonseca, José Melo Cristino, Álvaro Ayres Pereira, Cátia Caneiras
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2024-02-01
Seri Bilgileri:	Frontiers in Microbiology
Konular:	extensively drug-resistant Pseudomonas aeruginosa antimicrobial resistance difficult-to-treat infections ceftazidime-avibactam ceftolozane-tazobactam
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1347521/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!